Figure 8 Investment Strategies LLC Increases Stock Position in Waters Corporation $WAT

Figure 8 Investment Strategies LLC grew its holdings in Waters Corporation (NYSE:WAT) by 46.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,793 shares of the medical instruments supplier’s stock after purchasing an additional 2,471 shares during the quarter. Waters makes up approximately 2.1% of Figure 8 Investment Strategies LLC’s portfolio, making the stock its 15th largest holding. Figure 8 Investment Strategies LLC’s holdings in Waters were worth $2,336,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the stock. UMB Bank n.a. lifted its stake in Waters by 2.8% in the 2nd quarter. UMB Bank n.a. now owns 1,055 shares of the medical instruments supplier’s stock valued at $368,000 after buying an additional 29 shares in the last quarter. Integrated Wealth Concepts LLC lifted its position in shares of Waters by 2.9% in the first quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock valued at $386,000 after acquiring an additional 30 shares in the last quarter. Exchange Traded Concepts LLC boosted its stake in shares of Waters by 5.9% during the third quarter. Exchange Traded Concepts LLC now owns 630 shares of the medical instruments supplier’s stock valued at $189,000 after acquiring an additional 35 shares during the last quarter. Penserra Capital Management LLC increased its position in Waters by 13.1% during the 2nd quarter. Penserra Capital Management LLC now owns 327 shares of the medical instruments supplier’s stock worth $114,000 after purchasing an additional 38 shares in the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. increased its position in Waters by 1.8% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 2,264 shares of the medical instruments supplier’s stock worth $679,000 after purchasing an additional 41 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Stock Performance

NYSE:WAT opened at $387.07 on Friday. The company has a market cap of $23.05 billion, a P/E ratio of 35.58, a P/E/G ratio of 3.30 and a beta of 1.16. The firm’s 50 day moving average is $389.30 and its two-hundred day moving average is $340.54. Waters Corporation has a fifty-two week low of $275.05 and a fifty-two week high of $423.56. The company has a quick ratio of 1.08, a current ratio of 1.53 and a debt-to-equity ratio of 0.41.

Waters (NYSE:WAT) last released its quarterly earnings data on Tuesday, November 4th. The medical instruments supplier reported $3.40 EPS for the quarter, topping analysts’ consensus estimates of $3.21 by $0.19. The business had revenue of $799.89 million during the quarter, compared to the consensus estimate of $780.05 million. Waters had a return on equity of 36.59% and a net margin of 20.89%.The business’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same period in the prior year, the firm posted $2.93 EPS. Waters has set its FY 2025 guidance at 13.050-13.150 EPS and its Q4 2025 guidance at 4.450-4.550 EPS. Analysts expect that Waters Corporation will post 12.86 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on WAT shares. Morgan Stanley initiated coverage on shares of Waters in a research note on Monday, December 1st. They set an “equal weight” rating and a $423.00 price target on the stock. Rothschild & Co Redburn assumed coverage on shares of Waters in a research report on Wednesday, October 8th. They set a “buy” rating and a $390.00 target price on the stock. TD Cowen boosted their price target on Waters from $345.00 to $390.00 and gave the company a “hold” rating in a report on Wednesday, November 5th. Redburn Partners set a $390.00 price target on Waters in a research note on Wednesday, October 8th. Finally, Rothschild Redb upgraded Waters to a “strong-buy” rating in a report on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $395.00.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.